Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.08.041Source: DataRank Database

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 is a research paper published in Journal of the American College of Cardiology (2020). On theSindex it has a DataRank of 0.926. It has been cited 480 times.

N/A

0.926DataRank · unranked

Scored on demand from live citation data

Open Access480 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 10.98)OA: bronzeTopics (58)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.926

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (21)

Anuradha Lala ORCID,Emilia Bagiella ORCID,Helena Chang ORCID,Pedro Moreno ORCID,Elisabet Pujadas ORCID

Live enrichment

PubMed:32860872 PMC:PMC7449655 OpenAlex:https://openalex.org/W3081515108

NCATS NIH HHS

Grant: UL1 TR001433

National Institutes of Health

FWCI

10.98

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttps://www.sciencedirect.com/science/article/pii/S0735109720364081/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0735109720364081/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0735109720364081?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0735109720364081?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jacc.2020.08.041

Fields of Study

COVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementLong-Term Effects of COVID-19AgedAnticoagulantsAutopsyBetacoronavirusBlood CoagulationCOVID-19Coronavirus InfectionsFemaleHemorrhageHospital MortalityHospitalizationHumansMaleNew York CityOutcome and Process Assessment, Health CarePandemicsPneumonia, ViralPost-Exposure ProphylaxisRisk AdjustmentSARS-CoV-2Thromboembolism

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2AgedAnticoagulantsAutopsyBlood CoagulationFemaleHemorrhageHospitalizationHumansMaleNew York CityOutcome and Process Assessment, Health CarePneumonia, ViralThromboembolismHospital MortalityCoronavirus InfectionsRisk AdjustmentPost-Exposure ProphylaxisPandemics

Keywords

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicinePathologyInternal medicineDiseaseInfectious disease (medical specialty)MortalityAnticoagulationIntubationCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)

10.6084/m9.figshare.20035806.v1figshare

10.6084/m9.figshare.20035806figshare

Additional file 1 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579665.v1figshare

Additional file 1 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579665figshare

Additional file 2 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579671.v1figshare

Additional file 2 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579671figshare

Additional file 3 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579674.v1figshare

Additional file 3 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579674figshare

Additional file 4 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579677.v1figshare

Additional file 4 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579677figshare

Additional file 5 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579680.v1figshare

Additional file 6 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579683.v1figshare

Additional file 5 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579680figshare

Additional file 6 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579683figshare

Additional file 7 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579686.v1figshare

Additional file 7 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579686figshare

Additional file 8 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579689.v1figshare

Additional file 8 of Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis

10.6084/m9.figshare.20579689figshare

Additional file 1 of Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic

10.6084/m9.figshare.22616159.v1figshare

Additional file 1 of Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic

10.6084/m9.figshare.22616159figshare